Talphera (TLPH) Liabilities from Discontinued Operations (2022 - 2026)
Talphera (TLPH) posted quarterly Liabilities from Discontinued Operations of 650000.0 for Q1 2026, little changed year-over-year from 650000.0 in Q1 2025, and little changed quarter-over-quarter from 650000.0 in Q4 2025.
Talphera (TLPH) Liabilities from Discontinued Operations (2022 - 2026) Analysis & Trends
Talphera's Liabilities from Discontinued Operations history runs 5 years deep, the most recent figure standing at 650000.0 for Q1 2026.
- In Q1 2026, Liabilities from Discontinued Operations changed 0.0% year-over-year to 650000.0; the TTM figure through Mar 2026 stood at 650000.0 (changed 0.0% YoY), while the FY2025 annual figure was 650000.0, down 10.1% from the prior year.
- Liabilities from Discontinued Operations for Q1 2026 stood at 650000.0, roughly flat from 650000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 4620000.0 in Q4 2022, with the low at 650000.0 in Q1 2025.
- The 5-year median for Liabilities from Discontinued Operations is 723000.0 (2024), against an average of 1225615.38.
- The sharpest annual moves came in 2023 and 2026: Liabilities from Discontinued Operations tumbled 84.18% in 2023, then changed 0.0% in 2026.
- Talphera's Liabilities from Discontinued Operations stood at 4620000.0 in 2022, then sank by 84.18% to 731000.0 in 2023, then slipped by 1.09% to 723000.0 in 2024, then dropped by 10.1% to 650000.0 in 2025, then changed by 0.0% to 650000.0 in 2026.
- Business Quant data shows TLPH's Liabilities from Discontinued Operations at 650000.0 in Q1 2026, 650000.0 in Q4 2025, and 650000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Talphera | 89.88 Mn | 89.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 650,000.00 |
| Jun 30, 2026 | 650,000.00 |
| Mar 31, 2026 | 650,000.00 |
| Mar 31, 2026 | 650,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 650,000.00 |
| Sep 30, 2025 | 650,000.00 |
| Jun 30, 2025 | 650,000.00 |
| Jun 30, 2025 | 650,000.00 |
| Mar 31, 2025 | 650,000.00 |
| Mar 31, 2025 | 650,000.00 |
| Dec 31, 2024 | 723,000.00 |
| Dec 31, 2024 | 723,000.00 |
| Sep 30, 2024 | 723,000.00 |
| Sep 30, 2024 | 723,000.00 |
| Jun 30, 2024 | 723,000.00 |
| Jun 30, 2024 | 723,000.00 |
| Mar 31, 2024 | 730,000.00 |
| Mar 31, 2024 | 730,000.00 |